This bill establishes a temporary funding mechanism for the United States Victims of State Sponsored Terrorism Fund by requiring the Treasury Department to loan $3 billion annually to the fund for fiscal years 2027, 2028, and 2029. The borrowed money must be distributed immediately to victims as part of the annual payment and cannot be saved for future use. Interest on these loans will be set by the Treasury based on market rates and will be repaid only from future fines and penalties collected from state sponsors of terrorism after the fund ends. The authority to make these loans expires on September 30, 2029, and the funds are treated as direct spending rather than new appropriations.
The USA Act directs the National Institute of Standards and Technology to advance international standards for artificial intelligence and other emerging technologies by promoting private sector-led processes and strengthening public-private partnerships. To improve U.S. involvement, the bill requires the institute to provide Congress with a briefing on current standards activities and to create a web portal that helps industry and government agencies find and join these efforts. Additionally, the legislation establishes a five-year pilot program that awards grants to eligible organizations to host standards meetings within the United States, aiming to increase domestic participation in global technical standardization.
The K-12 AI Literacy and Readiness Act of 2026 amends the Elementary and Secondary Education Act to allow federal funding for artificial intelligence education in schools. This legislation directly affects states, local school districts, and educational staff by permitting the use of funds to teach students how to use AI safely and responsibly. Additionally, the bill authorizes money for professional development programs that equip teachers, librarians, and administrators with the skills to teach and utilize AI effectively. By adding these specific allowable uses to existing federal education grants, the act provides a clear pathway for integrating AI literacy into the K-12 curriculum.
This bill, known as the HERO Act, creates a federal grant program to help schools purchase opioid overdose reversal drugs and develop emergency response plans and educational resources for students and staff. Schools receiving federal funding would be required to report any distribution of these reversal drugs to federal tracking systems. The grants would be awarded competitively, with priority given to schools in areas with high rates of opioid overdoses, and recipients would need to submit annual reports on how they used the funds and implemented safety measures.
The SAFE CATTLE Act requires the U.S. Departments of Agriculture and Interior to coordinate federal efforts to prevent, monitor, and eradicate New World screwworm - a pest that attacks livestock and wildlife - across federal lands managed by agencies like the National Park Service and Fish and Wildlife Service. It mandates joint surveillance protocols, outbreak response plans with state officials, and science-based strategies to protect livestock industries and food supply chains. The bill also requires annual reports to Congress detailing interagency progress, outbreak responses, and recommendations for improving pest control until screwworm is contained south of Panama. This legislation directly affects federal land managers, livestock producers, and the broader agricultural economy by establishing a formal federal framework for addressing this specific animal health threat.
The Whale CHARTS Act of 2026 establishes a program to protect migratory whales and other large cetaceans through improved mapping, monitoring, and mitigation measures. It requires the creation of detailed, high-resolution maps of whale habitats, including calving grounds and migration routes, which will be integrated into vessel navigation systems to prevent collisions. The bill authorizes $8 million annually through 2030 for mapping, surveys, and a $10 million grant program to fund new detection technologies that reduce harmful interactions between whales and ocean users. It also mandates regular reporting to Congress on the program's effectiveness and progress in filling knowledge gaps about whale habitats.
HR 6213, the Heat Workforce Standards Act of 2025, prohibits the U.S. Department of Labor from finalizing, implementing, or enforcing OSHA's proposed "Heat Injury and Illness Prevention" standard (published August 30, 2024). This bill directly blocks the specific regulatory proposal targeting heat safety in both outdoor and indoor work settings. It does not create new requirements or affect workers; it solely prevents the implementation of the existing OSHA proposal. The bill is procedural, focusing on halting a regulatory action rather than establishing new policy.
This bill reauthorizes funding for the C.W. Bill Young Cell Transplantation Program, setting $31 million for fiscal year 2025 and $33 million annually for fiscal years 2027-2031. It also extends the deadline for the national cord blood inventory program from 2026 to 2031. The legislation directly affects stem cell research programs and cord blood banks by maintaining federal funding levels and prolonging the inventory program’s timeline. These provisions ensure continuity for existing research infrastructure and blood bank operations without introducing new policy changes.
This bill reauthorizes federal programs focused on preventing and responding to tick-borne diseases through 2026-2030, extending existing efforts beyond their previous expiration. It updates the National Strategy for Vector-Borne Diseases to emphasize identifying, reporting, preventing, and responding to these illnesses. The bill modifies two sections of the Public Health Service Act to continue funding for health departments working on vector-borne disease control. It directly affects public health programs and state/local health departments managing tick-borne disease prevention and response.
HR 4123, the FIT Procurement Act, modernizes federal information and communications technology (ICT) procurement by requiring new training for federal acquisition staff and streamlining processes to boost small business participation. The bill mandates a cross-functional ICT training program covering cloud computing, AI, cybersecurity, and commercial tech adoption, with learning objectives focused on outcome-based contracting and reducing waste. It increases simplified acquisition thresholds ($250,000 to $500,000) and micro-purchase limits ($10,000 to $25,000) to reduce administrative barriers. The Act also directs the Comptroller General to assess small business participation in federal tech contracts and requires agencies to eliminate unnecessary procedural hurdles for small businesses. These changes directly affect federal procurement staff, small businesses competing for contracts, and executive agencies managing ICT acquisitions.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
HR 2821, the FDA Modernization Act 3.0, requires the FDA to update regulatory language within one year of enactment. It directs the agency to replace all references to "animal tests" with "nonclinical tests" in 22 specific sections of the Code of Federal Regulations related to drug development and approval processes. The bill also adds a definition for "nonclinical test" into relevant FDA regulations to align with prior legislative changes. This update applies directly to pharmaceutical manufacturers and FDA reviewers who follow these regulatory guidelines during drug development. The changes aim to modernize terminology without altering current testing requirements.
